Effect of endothelin‐1 on the blood pressure response to acute hypoxia and hyperoxia in healthy young men
Physiological Reports · 2024
DOI: 10.14814/phy2.70004 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Physiological Reports, 2024. Verfasst von Anna M Gonsalves und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Exercise Physiology, University of Missouri, Columbia, Missouri, USA. Hauptthemen laut MEDLINE: Hyperoxia, Blood Pressure, Hypoxia, Endothelin-1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NHLBI NIH HHS, Mayo Clinic Center for Biomedical Discovery.
Abstract (Originalsprache)
Endothelin‐1 (ET‐1) and its receptors are linked to increases in sensitivity of the chemoreceptors to hypoxic stress and the development of hypertension in preclinical models. We hypothesized ET receptor antagonism would lower resting blood pressure (BP) as well as the acute BP response to chemoreflex stress. Twenty‐four men (31 ± 5 years, 26 ± 3 kg/m 2 ) completed two study visits (control, bosentan). On each visit, BP was assessed under three conditions: (1) normoxia (F i O 2 0.21), (2) chemoreflex excitation via hypoxia (F i O 2 0.05–0.21), (3) chemoreflex inhibition via hyperoxia (F i O 2 1.00). Bosentan increased plasma ET‐1 (0.94 ± 0.90 to 1.27 ± 0.62 pg/mL, p = 0.004), supporting receptor blockade. Resting diastolic (73 ± 5 to 69 ± 7 mmHg, p = 0.007) and mean (93 ± 7 to 88 ± 7 mmHg, p = 0.005) BP were reduced following bosentan compared to control with no change in systolic BP ( p = 0.507). The mean BP response to both acute hypoxia (−0.48 ± 0.38 to −0.25 ± 0.31 mmHg/%, p = 0.004) and hyperoxia (area under the curve −93 ± 108 to −27 ± 66 AU, p = 0.018) were attenuated following bosentan. Acute ET receptor inhibition attenuates the rise in BP during chemoreflex excitation as well as the fall in BP during chemoreflex inhibition in healthy young men. These data support a role for ET‐1 in control of resting BP, possibly through a chemoreceptor‐mediated mechanism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Exercise Physiology, University of Missouri, Columbia, Missouri, USA.
- Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota, USA.
- Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri, USA.
- Department of Medicine, University of Missouri, Columbia, Missouri, USA.
- Research Service, Harry S. Truman Memorial Veterans' Hospital, Columbia, Missouri, USA.
ORCID-Profile: Jacqueline K Limberg
Förderung
- NIH HHS
- NHLBI NIH HHS
- Mayo Clinic Center for Biomedical Discovery
- NIA NIH HHS
- National Institutes of Health
- Mayo Clinic
Zitieren
APA
Gonsalves, A. M., Baker, S. E., Jacob, D. W., Harper, J. L., Manrique-Acevedo, C. M., & Limberg, J. K. (2024). Effect of endothelin‐1 on the blood pressure response to acute hypoxia and hyperoxia in healthy young men. Physiological Reports. https://doi.org/10.14814/phy2.70004
Vancouver
Gonsalves AM, Baker SE, Jacob DW, Harper JL, Manrique-Acevedo CM, Limberg JK. Effect of endothelin‐1 on the blood pressure response to acute hypoxia and hyperoxia in healthy young men. Physiological Reports. 2024. doi:10.14814/phy2.70004
BibTeX
@article{Gonsalves2024,
author = {Gonsalves, Anna M and Baker, Sarah E and Jacob, Dain W and Harper, Jennifer L and Manrique-Acevedo, Camila M and Limberg, Jacqueline K},
title = {Effect of endothelin‐1 on the blood pressure response to acute hypoxia and hyperoxia in healthy young men},
journal = {Physiological Reports},
year = {2024},
doi = {10.14814/phy2.70004}
}
EUVIMED